Alpha-gal Allergen Inclusion Act
- Sponsor
- Rep. Van Drew, Jefferson [R-NJ-2]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Feb 10, 2025
Bottom line
The Alpha-gal Allergen Inclusion Act mandates clear labeling for foods containing alpha-gal, aiming to protect individuals with this specific tick-borne allergy.
What it actually does
This bill amends the Federal Food, Drug, and Cosmetic Act to include galactose-alpha-1,3-galactose, commonly known as alpha-gal, in the definition of "major food allergen." This designation would require food manufacturers to clearly label products containing alpha-gal, similar to how other major allergens like peanuts or milk are currently labeled. The bill specifies what constitutes alpha-gal for labeling purposes, including ingredients from certain mammals and red algae, while excluding ingredients from alpha-gal-knockout mammals if levels are undetectable.
Proponents argue
Supporters argue that adding alpha-gal to the list of major food allergens is a critical public health measure, providing necessary protection for individuals who suffer from alpha-gal syndrome, a potentially life-threatening allergic reaction to certain mammalian products. They contend that clear labeling will empower consumers to make informed choices, prevent accidental exposure, and improve the quality of life for those affected by this increasingly recognized condition.
Opponents contend
Critics might argue that expanding the list of major food allergens could impose additional regulatory burdens and costs on food manufacturers, potentially leading to increased food prices or complexities in supply chains. Some may also suggest that the prevalence of alpha-gal syndrome, while growing, does not yet warrant the same level of regulatory intervention as more common allergens, or that existing general allergen labeling guidelines are sufficient.
The bill is very short and straightforward, allowing for quick comprehension by any interested reader.
Section 2
Inclusion of Alpha-gal in Major Food Allergen Definition
This provision amends the Federal Food, Drug, and Cosmetic Act to officially recognize galactose-alpha-1,3-galactose, commonly known as alpha-gal, as a major food allergen. This means that food products containing alpha-gal will be subject to the same strict labeling requirements as other major allergens like peanuts, tree nuts, milk, eggs, fish, shellfish, soy, and wheat. The amendment clarifies that alpha-gal includes ingredients from non-catarrhine primate mammals and red algae in the order Gigartinales, but excludes certain mammal-derived ingredients if alpha-gal is undetectable.
Supporters argue
Supporters argue this provision is essential for public health, as alpha-gal syndrome can cause severe, delayed allergic reactions, and current labeling laws do not adequately protect affected individuals. They contend that standardized labeling will prevent accidental exposures, reduce emergency room visits, and provide peace of mind for those managing the allergy.
Critics contend
Opponents, if any, might argue that the scope of ingredients defined as alpha-gal could be overly broad, leading to unnecessary restrictions or increased costs for manufacturers who might need to re-evaluate ingredient sourcing or production lines. They might also suggest that the scientific understanding of alpha-gal and its prevalence is still evolving, and a more gradual approach to regulation might be preferable.
Tradeoffs
The provision balances the public health benefit of protecting individuals with alpha-gal syndrome against the potential compliance costs and operational adjustments required from the food industry. It also navigates the scientific complexities of defining alpha-gal, including specific inclusions and exclusions, to ensure effective yet practical regulation.
The bill specifies that "galactose-alpha-1,3-galactose" includes ingredients derived from non-catarrhine primate mammals and red algae in the order Gigartinales, but explicitly excludes mammal-derived ingredients where the Secretary determines alpha-gal is not present above a detectable limit (e.g., from alpha-gal-knockout mammals).
Section 2(a)(3)(B) and (C) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(qq))
Why it matters:This is standard legislative practice for defining terms and scope within an amendment, ensuring clarity for regulatory implementation.
Case for: Supporters argue these definitions are crucial for precise and effective regulation, preventing both under- and over-inclusion of ingredients, thereby protecting consumers without unduly burdening industry.
Case against: Critics might argue that the specific scientific definitions could become outdated as research evolves, potentially requiring future amendments or creating ambiguity for novel food products.
Estimated impact: This detail significantly impacts which specific food products and ingredients will fall under the new labeling requirements, affecting both consumers with alpha-gal syndrome and relevant food manufacturers.